Volgen
Kim Sweeny
Kim Sweeny
Senior Research Fellow, Victoria University
Geverifieerd e-mailadres voor vu.edu.au
Titel
Geciteerd door
Geciteerd door
Jaar
Scaling-up treatment of depression and anxiety: a global return on investment analysis
D Chisholm, K Sweeny, P Sheehan, B Rasmussen, F Smit, P Cuijpers, ...
The Lancet Psychiatry 3 (5), 415-424, 2016
15012016
Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework
K Stenberg, H Axelson, P Sheehan, I Anderson, AM Gülmezoglu, ...
The Lancet 383 (9925), 1333-1354, 2014
4172014
Adolescence and the next generation
GC Patton, CA Olsson, V Skirbekk, R Saffery, ME Wlodek, PS Azzopardi, ...
Nature 554 (7693), 458-466, 2018
3702018
Building the foundations for sustainable development: a case for global investment in the capabilities of adolescents
P Sheehan, K Sweeny, B Rasmussen, A Wils, HS Friedman, J Mahon, ...
The Lancet 390 (10104), 1792-1806, 2017
3212017
Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services
MY Bertram, K Sweeny, JA Lauer, D Chisholm, P Sheehan, B Rasmussen, ...
The Lancet 391 (10134), 2071-2078, 2018
1962018
Study Group for the Global Investment Framework for Women's Children's Health. Advancing social and economic development by investing in women’s and children’s health: a new …
K Stenberg, H Axelson, P Sheehan, I Anderson, AM Gülmezoglu, ...
Lancet 383 (9925), 1333-1354, 2014
672014
Returns on investment in the continuum of care for reproductive, maternal, newborn, and child health
K Stenberg, K Sweeny, H Axelson, M Temmerman, P Sheehan
Reproductive, maternal, newborn, and child health: disease control …, 2016
342016
A model of the monetary sector
WE Norton, AM Cohen, KM Sweeny
RBA Research Discussion Papers, 1970
291970
Technology trends in drug discovery and development: implications for the development of the pharmaceutical industry in Australia
K Sweeny
Victoria University, 2002
272002
Health and the economy: the impact of wellness on workforce productivity in global markets
B Rasmussen, K Sweeny, P Sheehan
US Chamber of Commerce, 2016
232016
Reduced road traffic injuries for young people: a preliminary investment analysis
J Symons, E Howard, K Sweeny, M Kumnick, P Sheehan
Journal of Adolescent Health 65 (1), S34-S43, 2019
222019
The role of the Basic Public Health Service program in the control of hypertension in China: results from a cross-sectional health service interview survey
J Qin, Y Zhang, M Fridman, K Sweeny, L Zhang, C Lin, L Mao
PLoS One 16 (6), e0217185, 2021
212021
Economic costs of absenteeism, presenteeism and early retirement due to ill health: a Focus on Brazil
B Rasmussen, K Sweeny, P Sheehan
Victoria Institute of Strategic Economic Studies (VISES), Victoria University, 2015
212015
Reductions in stillbirths—more than a triple return on investment
P ten Hoope-Bender, K Stenberg, K Sweeny
The Lancet 387 (10018), e14-e16, 2016
192016
Trends in the use and cost of pharmaceuticals under the Pharmaceutical Benefits Scheme
K Sweeny
Victoria University, 2002
142002
A health system–based investment case for adolescent health
K Sweeny, HS Friedman, P Sheehan, M Fridman, H Shi
Journal of Adolescent Health 65 (1), S8-S15, 2019
132019
Key aspects of the Australian Pharmaceutical Benefits Scheme
K Sweeny
Victoria University of Technology, 2007
132007
The impact of further PBS reforms: report to medicines Australia
K Sweeny
Centre for Strategic Economic Studies, Victoria University, 2013
112013
The impact of copayments and safety nets on PBS expenditure
K Sweeny
Australian Health Review 33 (2), 215-230, 2009
112009
The pharmaceutical industry in Australia
K Sweeny
Victoria University of Technology, 2007
112007
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20